Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

December 1 2023 - GSK pulls ahead of Pfizer in RSV vaccine market as Arexvy nears blockbuster status

GSK pulls ahead of Pfizer in RSV vaccine market as Arexvy nears blockbuster status
Pfizer cans twice-daily oral obesity program
3 medtech spinoffs that reshaped the industry in 2023
FDA starts review of Padcev/Keytruda for bladder cancer
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NexMed shares sink on Novartis decision

Yahoo/AP

Tuesday, August 26, 2008 - 5:32pm

tags:

J&J Schizophrenia Drug Faces FDA Delay

TheStreet.com

Tuesday, August 26, 2008 - 5:31pm

tags:

Bristol, Pfizer to delay clot drug after setback

Reuters

Tuesday, August 26, 2008 - 5:30pm

tags:

Abbott: Rapid Exchange of Fire

Motley Fool

Tuesday, August 26, 2008 - 5:29pm

tags:

Baxter Ready to Sop Up Additional Revenue

Motley Fool

Tuesday, August 26, 2008 - 3:43pm

tags:

Sangamo rises as trial show SB-509 improved function for patients with damaged nerves

Yahoo/AP

Tuesday, August 26, 2008 - 3:41pm

tags:

Biogen, Elan Drug Gets New FDA Warning

Yahoo/TheStreet.com

Tuesday, August 26, 2008 - 3:38pm

tags:

Cytokinetics shares rise ahead of study data

Yahoo/AP

Tuesday, August 26, 2008 - 1:23pm

tags:

Drug Safety Updates For Elan, Biogen, Amylin & Lilly

CNBC

Tuesday, August 26, 2008 - 11:16am

tags:

Which Drug Websites Do Doctors Visit The Most?

Pharmalot

Tuesday, August 26, 2008 - 9:30am

tags:

Amylin Shares Gain Ground on Outlook for Byetta

Seeking Alpha

Tuesday, August 26, 2008 - 9:29am

tags:

FDA Takes News of Tysabri-Related Infections In Stride

WSJ Online

Tuesday, August 26, 2008 - 8:42am

tags:

Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program

Yahoo

Tuesday, August 26, 2008 - 8:08am

tags:

Teva Pharma reports statistically significant results from phase III ADAGIO trial

RTT News

Tuesday, August 26, 2008 - 8:07am

tags:

King still interested in Alpharma after failed takeover bid

Pharma Times, UK

Tuesday, August 26, 2008 - 6:41am

tags:

Biogen, FDA Work to Alter Tysabri Label

WSJ Online

Tuesday, August 26, 2008 - 6:13am

tags:

Amylin, Eli Lilly to Address Byetta Concerns

TheStreet.com

Tuesday, August 26, 2008 - 6:11am

tags:

[video]Gurus Buy Amgen, Sell Shire

Forbes

Monday, August 25, 2008 - 5:33pm

tags:

Two Ways To Play: Merck Cured of Negative Outlook

Minyanville

Monday, August 25, 2008 - 5:24pm

tags:

Lipitor Marketing Raises Blood Pressure

Motley Fool

Monday, August 25, 2008 - 4:33pm

tags:

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

How Direct-to-Consumer Rx Platforms Help Patient Support Programs Succeed

Drug Channels

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels

Four Trends That Are Shaping the Future of Market Access

Drug Channels

FDA’s OPDP Issues Two New Untitled Letters

eye on fda

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?

Drug Channels